Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Amryt Pharma · Partial Lipodystrophy
Phase 4
Recruiting
12
2025-07
Industry sponsor intelligence
Amryt PharmaClinical Pipeline.
Lead-sponsor view of Amryt Pharma's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 2
- Recruiting
- 1
- Active
- 0
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 7
Pipeline overview
Programs by phase and activity.
Velocity
Amryt Pharma trials by start year
Study start year · indexed snapshot
Development
Trials by phase
2phase labels
Early Phase 10
Phase 10
Phase 20
Phase 31
Phase 41
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Metreleptin → | 2 | 0 | 0 | 1 | 1 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Amryt Pharma studies.
This page groups studies where Amryt Pharma is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
2 matching studies
Last registry update first